Phoenix 2024

Phoenix 2024



Gateway for Cancer Research

Facing the global threat of cancer head on

Cancer is a far reaching disease that requires a global response. According to the World Health Organization, more than 18 million people around the world are diagnosed with cancer every year.

To that end, Gateway is accelerating practice-changing discoveries in cancer care by harnessing the unrelenting passion of the research community and empowering patients to triumph over their disease. All guided by a clear vision: To shape a world in which a cancer diagnosis is no longer feared.


Since its inception in 1991, Gateway for Cancer Research has been harnessing the passion and drive of a global community of brilliant physicians, benevolent philanthropists and brave patients to advance transformational, early stage clinical trials for all types of cancer. This includes rare cancers for which funding is scarce as well as some of the most prevalent cancers affecting men, women and children today. Gateway exclusively funds Phase I and Phase II research trials, which often mark the first-in-human study of promising new cancer drugs and therapies. As such, they represent a critical first step in evaluating new cancer treatments that help patients live longer and feel better while working to end cancer as we know it.

To date, Gateway has invested more than $105 million to advance 227 cancer clinical trials. Conducted at esteemed institutions around the world, these trials have offered a beacon of HOPE and HEALING to more than 10,000 patients. In the process, they have altered the standard of care at some of the most trusted hospitals and health care institutions. Additionally, they have contributed to the development of new FDA-approved treatments and therapies that improve quality of life and save lives. In the process, Gateway has never forgotten that its work is ALWAYS and ONLY be about the patient.

Gateway is a 501c(3) nonprofit organization guided by a vision to shape a world in which a cancer diagnosis is no longer feared. Thanks to generous underwriting, 100% of every dollar Gateway receives directly funds early phase cancer research. In 2022 alone, Gateway awarded $9.7 million in grant funding.

10,000+ patients offered enrollment in
Gateway-funded studies
100% of every dollar directly
funds cancer research
$105+ MILLION million invested in Phase I & II
cancer clinical trials
227 cancer clinical trials
funded worldwide

Gateway invests in research that has the potential to forever change the face of cancer care through advancements in treatments and therapies that make a meaningful difference in the lives of patients. Thanks to the generosity of valued donors, we have achieved many significant breakthroughs in the quest to shape a world in which a cancer diagnosis is no longer feared.